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common to all countries, and the role of
legislators and the public in providing
judgments of how to control risks to an
acceptable level in a particular community.
In the first section, on smoking, the tech-
niques required to influence public opinion
and reduce the risk ofsmoking in France and
Finland are outlined. Although it is generally
accepted that the public should have a major
say in deciding the acceptability of risks, the
paradox presented by a government deciding
to legislate on smoking and then attempting
to influence public opinion to support it is not
tackled.
The international repercussions of legisla-
tion in this field are well illustrated by the
chapter on control of aflatoxin. The close
control imposed by importing countries on
aflatoxin in peanuts has a dramatic effect on
the economy and health of those whose
country depends on peanut production. The
interval between suspicion of a carcinogenic
risk and final control ofexposure can be very
long, as is illustrated by examples ofasbestos,
2-naphthylamine and vinyl chloride. The
problems of thresholds in carcinogenesis and
of comparison between chemical carcinogens
and radiation are also discussed.
Ifthe reader is expecting clear indications
of how to proceed in legislative or practical
control strategies, he will be disappointed,
because clarity is not yet present. To the
anglophile, the pragmatic but effective con-
trol of occupational exposure by the UK
government is heartening. The highlight of
the conference is in the well-balanced and
objective contribution by Dr Higginson in
the introduction, and Professor Doll in the
summing-up. To those interested in the field,
an incentive to read this volume comes from
2 quotatioqi from Higginson:
"It should not be forgotten that complex
biological processes are not basically altered
by legislation or legal definition, however
rational", and "I do not believe that the
cause of cancer prevention is served by
acrimonious adversary tactics and attempts
to denigrate the integrity of colleagues."
In general it is an interesting, if somewhat
superficial, look at the problems posed by
legislation and control of carcinogens. It will
be ofparticular value to scientists who do not
normally work in this field, because it gives
them an insight into the complexity of the
issues which have to be tackled.
I. F. H. PURCHASE
Tumor Associated Antigens and Their
Specific Immune Response. Eds F.
SPREAFICO and R. ARNON (1979). London:
Academic Press. 359 pp. £15.00, $31.00.
This book presents the proceedings of a
meeting in Milan in the summer of 1977 and
covers a wide range of topics in tumour
immunology. The list of contributors is im-
pressive, and several of the papers presented
give a valuable review of work in progress
in different laboratories. The major themes
discussed are antigen expression on virally
and chemically induced tumours (Comoglio,
Baldwin, Parmiani); activation of T-cell
cytotoxic mechanisms (Berke, Alexander,
Collavo, Keder, Scherter); natural immunity
against animal and human tumours (Herber-
man, Haller, Forni, Della Porta) and studies
ofantigen expression and immunocompetence
in cancer patients (Thompson, Adler, Stein).
Consideration is also given to the effects of
drug treatments on antigenicity and immuno-
competence in animals (Mantovani, Bon-
massar) and to the possible use of xenoan-
tisera in therapy (Arnon and Davies).
The book offers an attractive collection of
papers on major areas in tumour immunity
by recognized authorities. The papers are
generally critical and seek to subject the field
to the close scrutiny that is necessary if it is
to flourish. The extensive reference lists of
each contribution are also useful. This book
is to be recommended, though it is probable
that all the papers have now appeared in the
journal literature, as might be expected 2
years after the conference. To have them
combined in this form is a realistic addition
to any worker's bookshelf.
B. M. VOSE
Atlas of Clinical Cytology. P. LOPES
CARDOZO (1979). The Netherlands: Heine-
mann. 732 pp. £75.00.
This is an unusual book in that it presents
the accumulated experience of one man over
a period of more than 25 years. In the first
chapter Dr Lopes Cardozo states his basic
philosophy of clinical cytology, detailing the
diagnostic range of cytological techniques;
this would be useful reading for clinicians as
well as cytologists. The second chapter, on
criteria of malignancy, needs careful study to
appreciate the remainder of the atlas, par-BOOK REVIEWS 673
ticularly for those who are more accustomed
to Papanicolaou-stained material. Dr Cardozo
has always been a foremost advocate of the
use of Giemsa stain for cytological prepara-
tions, and most of the examples in the Atlas
are stained in this way. In this country
Papanicolaou's stain is in general use, even
when a Romanowski stain is also used for
some types of material. This difficulty should
not deter potential readers, who may find
themselves recognizing areas in which Giemsa
improves diagnostic accuracy.
The Atlas is profusely illustrated, with a
wide range of examples of benign and malig-
nant lesions, including a number of rare con-
ditions. The list of contents is detailed and
refers to the plates illustrating each con-
dition, making this a valuable bench book for
reference for those who use Giemsa stain;
some special stains are also illustrated. To
include 3300 coloured plates it has been
necessary to sacrifice the size of the pictures,
but this can be overcome by following the
author's advice and using a magnifying glass.
E. B. BUTLER
Pulmonary Metastasis. Eds L. WEISS and
H. A. GILBERT (1978). Boston: G. K. Hall
& Co. 336 pp. $34.50 (+15%0 outside US).
This book is the first of a projected series
of texts devoted to metastases at specific
sites. The first section deals with basic
mechanisms and pathways, and covers topics
such as the detachment of tumour cells, their
arrest in the circulation, models for micro-
metastases, and metastasis as an expression
of inherent tumour-cell heterogeneity. The
second part is concerned with patterns of
pulmonary metastasis viewed largely from a
pathological angle. The third section deals
with growth kinetics and the clinical manage-
ment of pulmonary metastases with particu-
lar reference to surgery and radiotherapy.
This bare outline indicates some general
characteristics of the book. The reader will
find an eclectic approach to pulmonary
metastasis, in which both clinical and experi-
mental aspects are skilfully presented. The
book provides an authoritative source of
recent work, and most readers will find a lot
of new material, as well as familiar material
set in new and interesting contexts. Certain
chapters are controversial, and the strong
emphasis on surgery is likely to provoke dis-
cussion. Curiouslylittle is saidabout palliative
treatment for pulmonary metastases.
Some of the contributions are a little
repetitive but, in general, this multidisci-
plinary approach to metastasis at one par-
ticular site has yielded an outstandingly
useful and interesting book. Its successors in
the series will be eagerly awaited.
R. L. CARTER
Mitomycin C. Current Status and De-
velopments. Eds S. K. CARTER and S. T.
CROOKE (1979). New York, San Francisco,
London: Academic Press. 254 pp. $20.00.
In his concluding remarks to this excellent
survey ofthe antitumour action ofMitomycin
C, Dr Carter points out that "an old drug can
always have a new lease of life". This agent
was recognized as an antitumour agent in the
late fifties and a considerable effort, especially
by Japanese investigators, has contributed to
a detailed knowledge of its mechanism of
action, to a programme of synthesizing
analogues and to the clinical testing both as
single agents and in combination with others.
This volume seeks to review all these aspects
in some detail.
The interesting opening chapter of S. T.
Crooke, entitled "Mitomycin C: An overview"
details its discovery and properties. This is
followed by a detailed and well written
account of the basic work that has been
undertaken to elucidate the mode of this
drug, by J. W. Lown. This chapter is an
invaluable component of the book, in that
the requirements for antitumour action in
this series of analogues have been concisely
and clearly documented and discussed at
the molecular level. The specialized multi-
pronged activity of the agent, involving
alkylation, cross-linking, hydroxyl radical
formation and its pH dependency are all
shown to be critically important to the quality
of its antitumour activity. Analogue de-
velopment is discussed by W. A. Remers,
together with their in vivo evaluation by
W. T. Bradner. This included some interesting
data on toxicity, especially in relation to
cisPDD. Ultrastructural changes due to
Mitomycin C are outlined by Y. Daskal and
S. T. Crooke, but the quality of the plates of
transmission electron microscopy is not
quite good enough to discern the nucleolar
segregation alluded to. A short and interesting